Skip to main content

Home/ Cancer/ Group items matching "EGFR" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma. - Wiley InterScience :: JOURNALS :: Journal der Deutschen Dermatologischen Gesellschaft - 0 views

www3.interscience.wiley.com/...abstract

2008 December study case report_case_report EGFR blocker cetuximab Erbitux COX-2 inhibitor celecoxib Celebrex Celebra combination therapy treatment skin cancer skin_cancer cutaneous SCC recurrent advanced medicine

shared by Matti Narkia on 15 Mar 09 - No Cached
  • Matti Narkia on 15 Mar 09
     
    Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma. Jalili A, Pinc A, Pieczkowski F, Karlhofer FM, Stingl G, Wagner SN. J Dtsch Dermatol Ges. 2008 Dec;6(12):1066-9. English, German. PMID: 19138272 DOI: 10.1111/j.1610-0387.2008.06861.x
Matti Narkia

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. - Clin Cancer Res. 2004 Sep 1 - 0 views

clincancerres.aacrjournals.org/...5930

2004 September study research in_vitro EGFR tyrosine_kinase inhibitors inhibitor inhibition TKI TKIs Iressa gefitinib COX-2 celecoxib Celebre3x Celebra head_and_neck_cancer head_and_neck cancer SCCHN SCC HNCA synergy medicine head neck oncology

shared by Matti Narkia on 15 Mar 09 - Cached
  • Matti Narkia on 15 Mar 09
     
    Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck. Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM. Clin Cancer Res. 2004 Sep 1;10(17):5930-9. PMID: 15355926
Matti Narkia

Factors Associated With Clinical Benefit From Epidermal Growth Factor Receptor Inhibitors in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck - OncologySTAT - 0 views

www.oncologystat.com/...noma_of_the_Head_and_Neck.html

2009 October oncologystat study review humans patients EGFR tyrosine kinase inhibitors TKI head_and_neck cancer head_and_neck_cancer hnca scchn recurrent metastatic advanced factors clinical benefits survival medline

shared by Matti Narkia on 08 Oct 09 - Cached
  • Matti Narkia on 08 Oct 09
     
    Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck. Cohen EE, Halpern AB, Kasza K, Kocherginsky M, Williams R, Vokes EE. Oral Oncol. 2009 Oct;45(10):e155-60. Epub 2009 Jul 7. PMID: 19586795
1 - 3 of 3
Showing 20▼ items per page